Skip to Main Content

Paper Details

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
Sci Signal
49
2018
Author NameAffiliation
Jessica M RusertNational Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Vijay RamaswamyThe Hospital for Sick Children
Vijay RamaswamyThe Hospital for Sick Children
Ulrike M LitzenburgerCenter for Personal Dynamic Regulomes, Stanford University
Lin QiTexas Children's Cancer Center, Baylor College of Medicine
Xiao-Nan LiTexas Children's Cancer Center, Baylor College of Medicine
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Michael D TaylorThe Hospital for Sick Children
Robert J Wechsler-ReyaNational Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Robert J Wechsler-ReyaRady Children's Institute for Genomic Medicine, Rady Children's Hospital
Robert J Wechsler-ReyaNational Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Robert J Wechsler-ReyaRady Children's Institute for Genomic Medicine, Rady Children's Hospital
Joshua E EliasStanford University School of Medicine
  • 1 - 15

Datasets